Auph short interest.

Approximately 10% of the overall float is currently held short. Two directors bought a collective 10,000 shares in early March. Prior to that several insiders sold just over $1.2 million worth of ...The average of price targets set by Wall Street analysts indicates a potential upside of 46.1% in Aurinia (AUPH). While the effectiveness of this highly sought-after metric is questionable, the ...About Aurinia Pharmaceuticals Stock (TSE:AUP) Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license ...Historical equity short-Interest data for all listed tickers starting 2018 ... AUPH (Aurinia Pharmaceuticals Inc) Start Date:2013-11-08. AUR (Aurora Innovation ...

The short story “Checkouts” by children and teen author Cynthia Rylant is about the games people play with each other and with themselves when they are interested in someone and do not know how to show it.To find anything from restaurants to clothing stores and auto repair shops in your area, just search Yelp.com. Though Yelp features information for businesses all around the world, you can narrow your search results down to a radius as shor...

Jan 5, 2023 · AUPH has multiple downside risks that investors need to consider when managing their position. First, Aurinia is still recording losses and reported a net loss of $82.1M for the first three ...

1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc.Live Short Interest data, Utilization, Cost to borrow and much more for Aurinia Pharmaceuticals Inc., Nasdaq:AUPHAurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ...Live Short Interest data, Utilization, Cost to borrow and much more for Aurinia Pharmaceuticals Inc., Nasdaq:AUPH

Live Short Interest data, Utilization, Cost to borrow and much more for Aurinia Pharmaceuticals Inc., Nasdaq:AUPH

Aurinia Pharmaceuticals ( NASDAQ: AUPH) soared 6.7% amid takeover speculation. The Aurinia ( AUPH) stock surge comes amid a report that a Gilead Sciences ( GILD) corporate jet made a trip to ...

It seems like the purpose of the document is to formalize the recent changes to the commercial partnership (originally announced here) as well as some of the items from the cooperation agreement released in February; particularly when it comes to the availability of stock warrants that Healios can execute once they achieve approvals for ARDS ... AUPH Short Interest SETTLEMENT DATE SHORT INTEREST AVG. DAILY SHARE VOLUME DAYS TO COVER 02/12/2021 5,442,521 4,199,973 1.295847. Reply Like. Delmar Price. 26 Feb. 2021. Investing Group.Short Float / Ratio: 13.17% / 8.88: Perf Quarter-4.23%: Sales: 158.85M: P/S: 8.19: EPS this Y: 31.36%: Inst Trans: 9.16%: Short Interest: 17.19M: Perf Half Y-5.03%: Book/sh: 2.73: …Aurinia Pharmaceuticals Ord. $ 7.29. AUPH (NASDAQ) -0.01. Short Squeeze Ranking™. view. Daily Short Sale Volume. view. Short Interest (Shares Short)Aurinia Pharmaceuticals last released its quarterly earnings results on November 2nd, 2023. The biotechnology company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.08. The business earned $54.52 million during the quarter, compared to the consensus estimate of $38.41 million.Historical equity short-Interest data for all listed tickers starting 2018 ... AUPH (Aurinia Pharmaceuticals Inc) Start Date:2013-11-08. AUR (Aurora Innovation ...Jan 5, 2023 · AUPH has multiple downside risks that investors need to consider when managing their position. First, Aurinia is still recording losses and reported a net loss of $82.1M for the first three ...

1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc.T2 Biosystems, Inc. Common Stock. $0.2229 +0.002. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US ...Arrow Financial Co. (NASDAQ:AROW – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 153,000 shares, an increase of 13.1% from the February 28th total of 135,300 shares. Based on an average trading volume of 34,700 shares, the […]WebShort interest for Aurinia Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Aurinia Pharmaceuticals's stock. Short interest data is...Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 16.4% in August marketbeat.com - September 17 at 6:15 AM: Here's Why We're Not At All Concerned With Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn Situation finance.yahoo.com - September 11 at 9:56 AMThat beat AUPH stock analysts' estimate for $22 million, according to FactSet. Per-share losses were 25 cents, narrower than expectations for 27 cents. Still, AUPH stock fell to its lowest point ...WebThe European Commission has approved Aurinia Pharmaceuticals' ( NASDAQ: AUPH) Lupkynis (voclosporin) for lupus nephritis. The approval triggers a $30M milestone payment from partner Otsuka ...

2021-12-28 Short sale volume (not short interest) for $FSR is 66%. http://shortvolumes.com/?t=FSR $KDP 44% $TNA 40% $SPDW 77% $AUPH 41%. 29 Dec 2021WebAurinia Pharmaceuticals (NASDAQ:NASDAQ: AUPH) received U.S. marketing approval for Lupkynis, a treatment for lupus nephritis [LN] , on Friday, Jan 22, 2021. The following Monday the share price ...

Aurinia Pharmaceuticals ( NASDAQ: AUPH) has said on Monday its collaboration partner Otsuka Pharmaceutical has filed a new drug application in Japan for its drug voclosporin. Voclosporin is a ...Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 16.4% in August marketbeat.com - September 17 at 6:15 AM: Here's Why We're Not At All Concerned With Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn Situation finance.yahoo.com - September 11 at 9:56 AMA high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …AUPH has a market cap of $1.3bn and a cash balance of $389mn. Research and development expenses were USD 9.9 million for 4Q. Selling, general and administrative expenses, inclusive of share-based ...Jun 29, 2023 · Aurinia Pharmaceuticals (AUPH) has begun to examine strategic alternatives that could include a potential sale or merger. ... Also, with 11%+ short interest, there should be some "motivated ... Short Float / Ratio: 13.17% / 8.88: Perf Quarter-4.23%: Sales: 158.85M: P/S: 8.19: EPS this Y: 31.36%: Inst Trans: 9.16%: Short Interest: 17.19M: Perf Half Y-5.03%: Book/sh: 2.73: P/B: 3.32: EPS next Y: 29.71%: ROA-14.80%: Target Price: 13.21: Perf Year: 76.61%: Cash/sh: 2.35: P/C: 3.85: EPS next 5Y-ROE-18.94%: 52W Range: 4.07 - 12.43: Perf YTD ... Mar 21, 2023 · Biotech stocks are very interest rate sensitive and I suspect once the Federal Reserve pivots and begins cutting interest rates, AUPH and the rest of the sector's stocks will move materially ... Short Interest. Percentage of Shares Shorted 11.97% of the outstanding shares of Aurinia Pharmaceuticals have been sold short. Short Interest Ratio / Days to …May 11, 2023 · AUPH is currently averaging 3,052,205 shares for the last 20 days. Earnings Outlook The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes.

AUPH is currently averaging 3,052,205 shares for the last 20 days. Earnings Outlook The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes.

30 Mar 2023 ... ... AUPH stock is predictable in the short/long term. According to price ... If an entity originates a loan that bears an off-market interest ...

Short Interest. Most Shorted. Largest Increase. Largest Decrease. ... The analyst firm set a price target for $15.00 expecting AUPH to rise to within 12 months (a possible 67.41% …This page provides short interest, short volume, short volume ratio, short borrow rates, and short squeeze score for the security. US: AUPH / Aurinia Pharmaceuticals Inc - Insider Trading Report This page provides data on the corporate insiders of Aurinia Pharmaceuticals Inc and their trades, trade performance, and predictive analysis. Jul 7, 2023 · NP. VQNPX - Vanguard Growth and Income Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value. 28,200. -40.63. AUPH short interest is 12%. More on Aurinia. Aurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock Value; Aurinia Pharmaceuticals: All In On Lupkynis - A Tough Bet;Are you a smaller woman looking for a new hairstyle? Short haircuts can be a great way to make a bold statement and show off your features. But with so many options available, it can be hard to know which one is right for you.TRKA Update - Nothing has changed with TRKA still sitting at well over 120% short interest. When in doubt just zoom out. This drop is expected after the last run-ups and the heavy shorting. Don't let them scare you off they are …May 11, 2023 · The largest shareholder of Aurinia Pharmaceuticals ( NASDAQ: AUPH) said it plans to withholder support for seven board members at the company's upcoming annual meeting. Iljin SNT, which has a 6.1% ... Aurinia Pharma press release ( NASDAQ: AUPH ): Q2 GAAP EPS of -$0.08 beats by $0.11. Revenue of $41.49M (+47.2% Y/Y) beats by $3.98M. Increases 2023 revenue guidance range to $150 - $160 million ...Introduction. This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at …Web

Spot open interest trends for Aurinia Pharmaceuticals - Common Shares (AUPH) and look for trend reversals. Evaluating open interest along with stock price data is useful to traders looking to confirm bullish or bearish sentiment. ... [Short ATM, Long OTM] Call Butterflies [Long ATM, Short OTM] Put Butterflies [Short ATM, Long OTM] Put ...Aurinia Pharmaceuticals posted its second quarter numbers on August 3rd. The company posted a GAAP loss of 8 cents a share, more than a dime a share better than expectations. Revenues rose 47% on ...Short Float / Ratio: 13.17% / 8.88: Perf Quarter-4.23%: Sales: 158.85M: P/S: 8.19: EPS this Y: 31.36%: Inst Trans: 9.16%: Short Interest: 17.19M: Perf Half Y-5.03%: Book/sh: 2.73: …Instagram:https://instagram. home.pricestop moving stocks of the dayhow do i start trading in cryptocurrencystokss Nov 2, 2023 · Interest income was $4.5 million at September 30, 2023 versus $1.5 million for the prior year period. Interest income was $12.4 million and $2.2 million for the nine months ended September 30 ... lfvn stockstarpax biopharma stock Jul 15, 2022 · Biogen has more recently been seen as a potential acquirer of AUPH after a Stat News report said that Biogen is working with Goldman Sachs to find potential targets for the company. Aurinia ( AUPH ... @HowIgraph @AverygraceMoore @theoriginalspa3 decreased short interest was not real good anyway as the shorts provide support. plus, even RLYP short interest rose into a buyout; it was near 20% if i remember correctly. the fact that AUPH short interest is so low actually has been baffling, but it may be that they use options abcam inc Short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) saw shorts transact 17.28 million shares and set a 9.89 days time to cover. Analysts on Wall Street suggest a consensus price target of $13.21, implying an increase of 29.75% to the stock’s recent value.Spot open interest trends for Aurinia Pharmaceuticals - Common Shares (AUPH) and look for trend reversals. Evaluating open interest along with stock price data is useful to traders looking to confirm bullish or bearish sentiment. ... [Short ATM, Long OTM] Call Butterflies [Long ATM, Short OTM] Put Butterflies [Short ATM, Long OTM] Put ...